Published in Intervirology on January 01, 1978
Natural isolates of simian virus 40 from immunocompromised monkeys display extensive genetic heterogeneity: new implications for polyomavirus disease. J Virol (1998) 1.30
Antigenic structure of simian virus 40 large tumor antigen and association with cellular protein p53 on the surfaces of simian virus 40-infected and -transformed cells. J Virol (1984) 1.04
Suppression of in vivo tumor formation induced by simian virus 40-transformed cells in mice receiving antiidiotypic antibodies. J Exp Med (1985) 0.99
The cellular secretory pathway is not utilized for biosynthesis, modification, or intracellular transport of the simian virus 40 large tumor antigen. J Virol (1987) 0.81
Absence of a structural basis for intracellular recognition and differential localization of nuclear and plasma membrane-associated forms of simian virus 40 large tumor antigen. Mol Cell Biol (1986) 0.79
A structural rationale for SV40 Vp1 temperature-sensitive mutants and their complementation. Protein Sci (2006) 0.79
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature (1992) 25.54
Role of simian virus 40 gene A function in maintenance of transformation. J Virol (1975) 6.63
Construction and characterization of an SV40 mutant defective in nuclear transport of T antigen. Cell (1984) 5.81
Spontaneous and carcinogen-induced tumorigenesis in p53-deficient mice. Nat Genet (1993) 3.85
The effect of arabinofuranosylcytosine on the growth cycle of simian virus 40. Virology (1965) 2.98
Secretion of neurotoxins by mononuclear phagocytes infected with HIV-1. Science (1990) 2.87
Epithelial mouse mammary cell line exhibiting normal morphogenesis in vivo and functional differentiation in vitro. Proc Natl Acad Sci U S A (1984) 2.44
DNA sequences similar to those of simian virus 40 in ependymomas and choroid plexus tumors of childhood. N Engl J Med (1992) 2.28
SV40-adenovirus "hybrid" populations: transfer of SV40 determinants from one type of adenovirus to another. Proc Natl Acad Sci U S A (1965) 2.27
Subcellular Localization of simian virus 40 large tumor antigen. J Virol (1979) 2.03
A mammary-specific model demonstrates the role of the p53 tumor suppressor gene in tumor development. Oncogene (2000) 2.03
Optimal conditions for uptake of exogenous DNA by Chinese hamster lung cells deficient in hypoxanthine-guanine phosphoribosyltransferase. Biochim Biophys Acta (1975) 1.95
Hepatitis B virus X protein interacts with a probable cellular DNA repair protein. J Virol (1995) 1.95
Hepatitis B virus transactivator X protein is not tumorigenic in transgenic mice. J Virol (1990) 1.80
Interaction of a simian papovavirus and adenoviruses. I. Induction of adenovirus tumor antigen during abortive infection of simian cells. J Bacteriol (1966) 1.79
Association of a cellular heat shock protein with simian virus 40 large T antigen in transformed cells. J Virol (1989) 1.76
Oncogenicity and cell transformation by papovavirus SV40: the role of the viral genome. Adv Cancer Res (1972) 1.73
Hepatitis B virus X protein interferes with cellular DNA repair. J Virol (1998) 1.62
Antigenic relationship of SV40 early proteins to purified large T polypeptide. Virology (1979) 1.61
The envelope glycoprotein of human immunodeficiency virus type 1 stimulates release of neurotoxins from monocytes. Proc Natl Acad Sci U S A (1993) 1.57
Increased sensitivity to the hepatocarcinogen diethylnitrosamine in transgenic mice carrying the hepatitis B virus X gene. Mol Carcinog (1996) 1.56
Transcription of mouse mammary tumor virus: identification of a candidate mRNA for the long terminal repeat gene product. J Virol (1983) 1.43
Natural simian virus 40 strains are present in human choroid plexus and ependymoma tumors. Virology (1995) 1.37
Phylogenetic and structural analyses of MMTV LTR ORF sequences of exogenous and endogenous origins. Virology (1993) 1.36
Differential ability of a T-antigen transport-defective mutant of simian virus 40 to transform primary and established rodent cells. Mol Cell Biol (1985) 1.30
Natural isolates of simian virus 40 from immunocompromised monkeys display extensive genetic heterogeneity: new implications for polyomavirus disease. J Virol (1998) 1.30
Variation in properties of plaque progeny of PARA (defective simian papovavirus 40)-adenovirus 7. J Virol (1969) 1.28
The retinoblastoma protein-binding region of simian virus 40 large T antigen alters cell cycle regulation in lenses of transgenic mice. Mol Cell Biol (1994) 1.27
Papovaviridae. Intervirology (1974) 1.26
Antigenic and immunogenic characteristics of nuclear and membrane-associated simian virus 40 tumor antigen. J Virol (1980) 1.26
Hepatitis B virus DNA in mononuclear cells and analysis of cell subsets for the presence of replicative intermediates of viral DNA. J Infect Dis (1986) 1.26
p53 mutations cluster at codon 249 in hepatitis B virus-positive hepatocellular carcinomas from China. Cancer Res (1992) 1.23
Hepatitis B virus integration event in human chromosome 17p near the p53 gene identifies the region of the chromosome commonly deleted in virus-positive hepatocellular carcinomas. Cancer Res (1991) 1.22
Replication in simian cells of defective viruses in an SV40-adenovirus "hybrid" population. J Bacteriol (1966) 1.21
The plasma-membrane-associated form of SV40 large tumor antigen: biochemical and biological properties. Biochim Biophys Acta (1986) 1.21
Differential phosphorylation of cytoplasmic and nuclear variants of simian virus 40 large T antigen encoded by simian virus 40-adenovirus 7 hybrid viruses. J Virol (1984) 1.21
Variants of defective simian papovavirus 40 (PARA) characterized by cytoplasmic localization of simian papovavirus 40 tumor antigen. J Virol (1969) 1.21
Demonstration of infectious deoxyribonucleic acid in transformed cells. I. Recovery of simian virus 40 from yielder and nonyielder transformed cells. J Virol (1972) 1.18
Modification of simian virus 40 large tumor antigen by glycosylation. Virology (1985) 1.18
Intracellular transport of SV40 large tumor antigen: a mutation which abolishes migration to the nucleus does not prevent association with the cell surface. Virology (1982) 1.17
Serological evidence of SV40 infections in HIV-infected and HIV-negative adults. J Med Virol (1998) 1.17
Mitogenic effects of the proto-oncogene and oncogene forms of c-H-ras DNA in human diploid fibroblasts. Mol Cell Biol (1986) 1.17
Fusion as a mediator of cytolysis in mixtures of uninfected CD4+ lymphocytes and cells infected by human immunodeficiency virus. Proc Natl Acad Sci U S A (1987) 1.17
Studies with human papilloma virus modeled after known papovavirus systems. J Natl Cancer Inst (1972) 1.17
Tumor suppressor p53 mutations and breast cancer: a critical analysis. Adv Cancer Res (1995) 1.16
Complementation between a defective monkey cell-adapting component and human adenoviruses in simian cells. Virology (1967) 1.14
Mammary tumorigenesis in 7,12-dimethybenzanthracene-treated C57BL x DBA/2f F1 mice. Cancer Res (1980) 1.14
Biochemical characterization of nuclear and cytoplasmic forms of SV40 tumor antigens encoded by parental and transport-detective mutant SV40-adenovirus 7 hybrid viruses. Virology (1980) 1.12
Association of SV40 large tumor antigen and cellular proteins on the surface of SV40-transformed mouse cells. Virology (1982) 1.11
Laryngeal papilloma: etiologic and therapeutic considerations. Ann Otol Rhinol Laryngol (1973) 1.08
Structural analysis of a hepatitis B virus genome integrated into chromosome 17p of a human hepatocellular carcinoma. J Virol (1988) 1.07
Extrachromosomal sequences of hepatitis B virus DNA in peripheral blood mononuclear cells of acquired immune deficiency syndrome patients. Proc Natl Acad Sci U S A (1986) 1.06
Role of the simian virus 40 gene A product in regulation of DNA synthesis in transformed cells. J Virol (1978) 1.06
SV40 DNA in human osteosarcomas shows sequence variation among T-antigen genes. Int J Cancer (1997) 1.05
Identification of a conserved sequence in the non-coding regions of many human genes. Nucleic Acids Res (1989) 1.05
Detection of mouse mammary tumor virus RNA in BALB/c tumor cell lines of nonviral etiologies. J Virol (1978) 1.04
Antigenic structure of simian virus 40 large tumor antigen and association with cellular protein p53 on the surfaces of simian virus 40-infected and -transformed cells. J Virol (1984) 1.04
Tissue culture adaptation of natural isolates of simian virus 40: changes occur in viral regulatory region but not in carboxy-terminal domain of large T-antigen. J Gen Virol (1997) 1.03
Transformation of primate and rodent cells by temperature-sensitive mutants of SV40. Cold Spring Harb Symp Quant Biol (1975) 1.03
Sequence analyses of human tumor-associated SV40 DNAs and SV40 viral isolates from monkeys and humans. J Neurovirol (1998) 1.01
Detection of simian virus 40 surface-associated large tumor antigen by enzyme-catalyzed radioiodination. Int J Cancer (1982) 1.01
Inactivation and density studies with PARA-adenovirus 7 (SV40-adenovirus "hybrid" population). J Immunol (1966) 1.00
Inhibition of nuclear migration of wild-type SV40 tumor antigen by a transport-defective mutant of SV40-adenovirus 7 hybrid virus. Virology (1980) 1.00
Detection and characterization of a glycoprotein encoded by the mouse mammary tumor virus long terminal repeat gene. J Virol (1991) 1.00
Suppression of in vivo tumor formation induced by simian virus 40-transformed cells in mice receiving antiidiotypic antibodies. J Exp Med (1985) 0.99
Low serum alpha-fetoprotein level in patients with hepatocellular carcinoma as a predictor of response to 5-FU and interferon-alpha-2b. Cancer (1993) 0.99
Structural comparisons of wild-type and nuclear transport-defective simian virus 40 large tumor antigens. Virology (1984) 0.98
Construction of SV40 deletion mutants and delimitation of the binding domain for heat shock protein to the amino terminus of large T-antigen. Virus Res (1994) 0.97
The role of SV40 gene A in the alteration of microfilaments in transformed cells. Exp Cell Res (1977) 0.96
Hepatitis B virus and hepatocellular carcinoma. Prog Med Virol (1992) 0.95
Comparative analysis of casein synthesis during mammary cell differentiation in collagen and mammary gland development in vivo. Dev Biol (1985) 0.95
Mutations in p53 are frequent in the preneoplastic stage of mouse mammary tumor development. Cancer Res (1993) 0.95
Properties of transformed hamster cells containing SV40 tumor antigen in the cytoplasm. Int J Cancer (1971) 0.95
Simian virus 40 regulatory region structural diversity and the association of viral archetypal regulatory regions with human brain tumors. Semin Cancer Biol (2001) 0.95
Detection of a complex of SV40 large tumor antigen and 53K cellular protein on the surface of SV40-transformed mouse cells. J Cell Biochem (1982) 0.94
Integrated state of subgenomic fragments of hepatitis B virus DNA in hepatocellular carcinoma from mainland China. J Natl Cancer Inst (1987) 0.94
SV40 large T-antigen: dual oncogene. Cancer Surv (1986) 0.94
Apolipoprotein B gene regulatory factor-2 (BRF-2) is structurally and immunologically highly related to hepatitis B virus X associated protein-1 (XAP-1). Biochemistry (1997) 0.94
Allelotype and loss of heterozygosity of p53 in primary and recurrent hepatocellular carcinomas. A study of 150 patients. Cancer (1994) 0.94
Molecular characterization of SV40 DNA in multiple samples from a human mesothelioma. Anticancer Res (2000) 0.94
Variation in properties of SV40-transformed simian cell lines detected by superinfection with SV40 and human adenoviruses. Virology (1971) 0.94
Transformation of mouse mammary epithelial cells by papovavirus SV40. Exp Mol Pathol (1984) 0.93
Comparison of ability of defective foreign genomes (PARA and MAC) carried by human adenoviruses to induce SV40 transplantation immunity. J Immunol (1967) 0.93
Characterization of simian cells tranformed by temperature-sensitive mutants of simian virus 40. J Virol (1976) 0.93
Polyomaviruses and human tumors: a brief review of current concepts and interpretations. Front Biosci (1999) 0.93
Consideration of PCR methods for the detection of SV40 in tissue and DNA specimens. Dev Biol Stand (1998) 0.92
Infrequent p53 mutations in 7,12-dimethylbenz[a]anthracene-induced mammary tumors in BALB/c and p53 hemizygous mice. Mol Carcinog (1994) 0.92
Expression of mammary tumor virus proteins in preneoplastic outgrowth lines and mammary tumors of BALB/cV mice. Cancer Res (1984) 0.92
Differential expression of poly(A)-adjacent sequences of mammary tumor virus RNA in murine mammary cells. Proc Natl Acad Sci U S A (1978) 0.92
Recent advances in molecular pathology. The state of the viral genome in cells transformed by simian virus 40: a review. Exp Mol Pathol (1972) 0.92
Surface T-antigen expression in simian virus 40-transformed mouse cells: correlation with cell growth rate. Mol Cell Biol (1985) 0.91
Simian virus 40 large T antigen and p53 are microtubule-associated proteins in transformed cells. Cell Growth Differ (1991) 0.91
Identification of a variable region at the carboxy terminus of SV40 large T-antigen. Virology (1996) 0.91
Antigenic analysis of tumors and sera from aimals inoculated with para-adenovirus populations. J Immunol (1966) 0.91
Mouse mammary tumor virus genome expression in chemical carcinogen-induced mammary tumors in low- and high-tumor-incidence mouse strains. Proc Natl Acad Sci U S A (1979) 0.91